Compared with normal tissues, SLC2A4 were significantly reduced in luminal, HER2 positive and triple negative breast cancers (p = 1.19E-11;p = 2.43E-11;p = 6.70E-12, respectively). The gene discussed is SLC2A4; the disease is triple-negative breast carcinoma.